Voyageur Pharmaceuticals (CVE:VM) Trading Up 14.7% – What’s Next?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price rose 14.7% during trading on Friday . The stock traded as high as C$0.20 and last traded at C$0.20. Approximately 615,500 shares traded hands during trading, an increase of 49% from the average daily volume of 411,916 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Stock Up 11.8 %

The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The stock’s fifty day simple moving average is C$0.09 and its two-hundred day simple moving average is C$0.07. The stock has a market capitalization of C$26.50 million, a P/E ratio of -19.00 and a beta of 0.32.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Further Reading

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.